Aase Berg

Dr. Aase Berg

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
SKSebastian Lorenz Knackstedt
Sebastian Lorenz Knackstedt
AGAthina Georgiadou
Athina Georgiadou
FAFalko Apel
Falko Apel
UAUlrike Abu-Abed
Ulrike Abu-Abed
CMChristopher A. Moxon
Christopher A. Moxon
BABorko Amulic
Borko Amulic
NETs contribute to malaria by promoting emergency granulopoiesis and endothelial binding of parasitized erythrocytes.

1 September 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
ABAndreas Barratt-Due
Andreas Barratt-Due
IOInge Christoffer Olsen
Inge Christoffer Olsen
KNKaterina Nezvalova-Henriksen
Katerina Nezvalova-Henriksen
TKTrine Kåsine
Trine Kåsine
FLFridtjof Lund-Johansen
Fridtjof Lund-Johansen
PAPål Aukrust
Pål Aukrust
In an add-on study of the WHO Solidarity trial, Norwegian investigators examined the effect of remdesivir and hydroxychloroquine on the degree of clinical respiratory failure, on SARS-CoV-2 viral l... Visual Remdesivir and Hydroxychloroquine: Effects on SARS-CoV-2 Clearance. In an add-on study of the WHO Solidarity trial, Norwegian investigators examined the effect of remdesivir and hyd... Background: New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) ...

18 December 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KOKari Otterdal
Kari Otterdal
ABAase Berg
Aase Berg
AMAnnika E. Michelsen
Annika E. Michelsen
SPSam Patel
Sam Patel
MTMarit G. Tellevik
Marit G. Tellevik
TUThor Ueland
Thor Ueland
The immune response during P. falciparum infection is a two-edged sword, involving dysregulation of the inflammatory responses with several types of immune cells participating. Here we examined T-cell, monocyte/macrophage and neutrophil activation during P. falciparum infection by using soluble activation markers for these leukocyte subsets. In a prospective cross-sectional study clinical data and blood samples were collected from adults in Mozambique with P. falciparum infection, with (n = 70) and without (n = 61) co-infection with HIV-1, as well as HIV-infected patients with similar symptoms but without malaria (n = 58) and healthy controls (n = 52). Soluble (s)CD25, sCD14, sCD163 and myeloperoxidase (MPO) as markers for T-cell, monocyte/macrophage and neutrophil activation, respectively as well as CX3CL1, granzyme B and TIM-3 as markers of T-cell subsets and T-cell exhaustion, were analyzed. All patient groups had raised levels of activation markers compared with healthy controls. Levels of sCD25 and MPO increased gradually from patient with HIV only to patient with malaria only, with the highest levels in the HIV/malaria group. In the malaria group as a whole, MPO, sCD14 and in particular sCD25 were correlated with disease severity. sCD163, sCD25 and in particular MPO correlated with the degree of parasitemia as assessed by qPCR. Patients with falciparum malaria also had signs of T-cell subset activation (i.e. increased granzyme B and CX3CL1) and T-cell exhaustion as assessed by high levels of TIM-3 particularly in patients co-infected with HIV. Our data support a marked immune activation in falciparum malaria involving all major leukocyte subsets with particular enhanced activation of neutrophils and T-cells in patients co-infected with HIV. Our findings also support a link between immune activation and immune exhaustion during falciparum malaria, particularly in relation to T-cell responses in patients co-infected with HIV.

15 December 2008 in Malaria Journal
Verified
Journal Article
Open access
PDF file
ABAase Berg
Aase Berg
SPSam Patel
Sam Patel
NLNina Langeland
Nina Langeland
BBBjørn Blomberg
Bjørn Blomberg
The potential impact of HIV-1 on falciparum malaria has been difficult to determine because of diagnostic problems and insufficient epidemiological data.

5 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
HSHeidi Syre
Heidi Syre
MOMarius Eduardo Brå Obreque
Marius Eduardo Brå Obreque
IDIngvild Dalen
Ingvild Dalen
ÅRÅse Garløv Riis
Åse Garløv Riis
ABAase Berg
Aase Berg
RCRebecca Jane Cox
Rebecca Jane Cox
The aim of this study was to evaluate the performances of three commercially available antibody assays for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies at different time points following SARS-CoV-2 infection. Sera from 536 cases, including 207 SARS-CoV-2 PCR positive, were tested for SARS-CoV-2 antibodies with the Wantai receptor binding domain (RBD) total antibody assay, Liaison S1/S2 IgG assay and Alinity i nucleocapsid IgG assay and compared to a two-step reference ELISA (SARS-CoV-2 RBD IgG and SARS-CoV-2 spike IgG). Diagnostic sensitivity, specificity, predictive values and Cohen’s kappa were calculated for the commercial assays. The assay’s sensitivities varied greatly, from 68.7% to 95.3%, but the specificities remained high (96.9–99.1%). The three tests showed good performances in sera sampled 31 to 60 days after PCR positivity compared to the reference ELISA. The total antibody test performed better than the IgG tests the first 30 days and the nucleocapsid IgG test showed reduced sensitivity two months or more after PCR positivity. Hence, the test performances at different time points should be taken into consideration in clinical practice and epidemiological studies. Spike or RBD IgG tests are preferable in sera sampled more than two months following SARS-CoV-2 infection.

19 February 2020 in Infection
Verified
Journal Article
Open access
PDF file
ABAase Berg
Aase Berg
SPSam Patel
Sam Patel
MTMarit G. Tellevik
Marit G. Tellevik
CHChristel G. Haanshuus
Christel G. Haanshuus
IDIngvild Dalen
Ingvild Dalen
NLNina Langeland
Nina Langeland
Purpose: When considering malaria disease severity, estimation of parasitemia in erythrocytes is important, but sometimes misleading, since the infected erythrocytes may be sequestered in peripheral capillaries. In African children and Asian adults with falciparum malaria, parasitemia as assessed by quantitative PCR (qPCR) in plasma seems to be a valuable indicator of disease severity, but data on African adults as well as the impact of co-infection with HIV is lacking. Methods: In 131 patients with falciparum malaria in a public tertiary teaching hospital in Mozambique, plasma malaria parasitemia as assessed by qPCR, compared to qualitative malaria PCR in blood cell fraction, was related to malaria disease severity and HIV co-infection. Results: Of the 131 patients with falciparum malaria, based on positive qualitative PCR in the blood cell fraction, 93 patients (72%) had positive malaria qPCR in plasma. Patients with severe malaria as defined by the WHO criteria had higher malaria quantitative plasma parasitemia (median 143 genomes/µL) compared to those with uncomplicated malaria (median 55 genomes/µL, p = 0.037) in univariate analysis, but this difference was attenuated after adjusting for age, sex and HIV co-infection (p = 0.055). A quarter of the patients with severe malaria had negative qPCR in plasma. Conclusions: This study of adult African in-patients with falciparum malaria with and without HIV co-infection, neither confirms nor rejects previous studies of malaria qPCR in plasma as an indicator of disease severity in patients with falciparum malaria. There is a need for further and larger studies to clarify if parasitemia as assessed malaria qPCR in plasma could be a surrogate marker of disease severity in falciparum malaria.